Related Experiment Video
Updated: Oct 9, 2025
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
12.0K
Secretases Related to Amyloid Precursor Protein Processing.
Xiaoling Liu1, Yan Liu2, Shangrong Ji1
1Key Laboratory of Cell Activities and Stress Adaptations, Ministry of Education, School of Life Sciences, Lanzhou University, South Tianshui Road, Lanzhou 730030, China.
Membranes
|December 23, 2021
Summary
Alzheimer's disease involves abnormal amyloid precursor protein (APP) metabolism. Targeting secretases, enzymes that process APP into amyloid-beta (Aβ), offers potential new therapies for this common neurodegenerative condition.
Area of Science:
- Neurodegenerative diseases
- Molecular biology
- Drug discovery
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder increasing with age.
- Abnormal amyloid precursor protein (APP) metabolism is a key pathological feature in AD.
- APP is cleaved by secretases to produce amyloid-beta (Aβ) peptides.
Purpose of the Study:
- To summarize the role of secretases in APP processing.
- To identify potential drug targets for Alzheimer's disease therapy.
Main Methods:
- Review of recent studies on APP processing pathways.
- Analysis of the involvement of secretases (β- and γ-secretases) in APP metabolism.
- Exploration of secretion pathways related to APP.
Main Results:
- Secretase activity is central to the production of amyloid-beta (Aβ).
- Dysregulation of APP processing by secretases contributes to AD pathogenesis.
- Specific secretases represent viable targets for therapeutic intervention.
Conclusions:
- Understanding secretase function in APP processing is crucial for AD research.
- Targeting secretases offers promising therapeutic strategies for Alzheimer's disease.
- Further investigation into APP secretase pathways may lead to novel AD treatments.
More Related Videos
10:08Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
12.0K
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
6.9K
Related Concept Videos
03:03Amyloid Fibrils
10.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.6K
01:39Mitochondrial Precursor Proteins
2.7K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.7K
01:13The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
01:33Overview of Secretory Vesicles
8.8K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.8K
01:32Export of Misfolded Proteins out of the ER
4.1K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.1K
01:24Caspases
12.8K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.8K